Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2010
06/23/2010EP1425423B1 Transcutaneous immunization against papillomavirus with papillomavirus virus-like particles
06/23/2010EP1416959B1 Liposomes prepared from the extractable lipids from a mycobacterium
06/23/2010EP1108036B1 Dengue viruses that are replication defective in mosquitos for use as vaccines
06/23/2010EP0790835B2 Specific immunotherapy of cancer using a live recombinant bacterial vaccine vector
06/23/2010CN1930284B Infectious bursal disease virus antigenic isolates and vaccines
06/23/2010CN1894275B Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
06/23/2010CN1820026B Human anti-IFN-gamma neutralizing antibodies as selective IFN-gamma pathway inhibitors
06/23/2010CN1777443B Methods of diagnosing and treating pre-eclampsia or eclampsia
06/23/2010CN101754980A Prevention and treatment of complement-associated eye conditions
06/23/2010CN101754979A Monoclonal antibodies for treatment of cancer
06/23/2010CN101754978A The ED-A antigen of fibrinogen is associated with the neovas culature of tumor metastases
06/23/2010CN101754976A Complexes of Grp94 with human immunoglobulin G
06/23/2010CN101754975A Recombinant vaccine against bluetongue virus
06/23/2010CN101754773A modified polysaccharides for conjugate vaccines
06/23/2010CN101754772A Antibodies to IL-6 and use thereof
06/23/2010CN101754771A Inhibition of tumor metastasis by anti neuropilin 2 antibodies
06/23/2010CN101754770A intradermal influenza vaccine
06/23/2010CN101754768A Survivin peptides as cancer vaccines
06/23/2010CN101748140A Schistosoma japonica glyceraldehyde-3-phosphate dehydrogenase gene and encoded protein and application thereof
06/23/2010CN101748139A Schistosoma japonica enolase gene and coding protein and application thereof
06/23/2010CN101748138A Schistosoma japonica superoxide dismutase gene and a coding protein and application thereof
06/23/2010CN101748128A Schistosoma japonica titin gene and coding protein and application thereof
06/23/2010CN101748127A Schistosoma japonica actin gene and a coding protein and application thereof
06/23/2010CN101747435A Monoclonal antibody (hybrid tumor) for neutralizing CYR61 and applications thereof
06/23/2010CN101747422A Schistosoma japonica fatty acid-binding protein and coding gene and application thereof
06/23/2010CN101747416A B-cell antigenic multi-epitope peptide linked in tandem in OmpU of vibrio mimicus, making method and application thereof
06/23/2010CN101745112A Treatment of TNFalpha related disorders
06/23/2010CN101745111A Method for restraining infiltration and metastasis of breast cancer cells by using target CCL 18 and application thereof
06/23/2010CN101745110A Yolk immune globulin (IgY) oral preparation and preparation method thereof
06/23/2010CN101745109A Method for preparing nasal-spray type influenza virus vaccine containing CpG ODN and poly I:G adjuvant
06/23/2010CN101745108A Avian influenza vaccine and preparation method thereof
06/23/2010CN101745107A Recombinant replication-defective adenoviral vector H5N1 subtype influenza genetic engineering vaccine
06/23/2010CN101745106A Porcine parvnvirus living vaccine and preparation method thereof
06/23/2010CN101745105A Inactivated vaccine for streptococcus suis and pasteurella multocida diseases and preparation method thereof
06/23/2010CN101745104A Tuberculosis subunit vaccine containing compound adjuvant
06/23/2010CN101215568B Anthrax resisting polypeptide and its application and preparation method
06/23/2010CA2653163A1 Methods for the treatment of acute myeloid leukemia
06/22/2010US7741465 Chimeric receptor genes and cells transformed therewith
06/22/2010US7741449 inhibit the biological activity of multiple interferon (IFN) alpha subtypes but do not substantially inhibit the biological activity of IFN alpha 21, IFN beta or IFN omega; autoimmune diseases, transplant rejection and graft versus host disease; immunoconjugates
06/22/2010US7741447 Antibody against tumor specific antigen as target
06/22/2010US7741445 Multidrug resistance proteins; xenobiotic transporters; counteracting the mechanism of drug resistance so to provide a longer and more effective course of chemotherapeutic drug treatment for cancer patients
06/22/2010US7741443 human C-type lectin; diagnosis, prevention and/or treatment of neoplastic disorders and diseases
06/22/2010US7741442 Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation
06/22/2010US7741439 Isolated stra6 polypeptides
06/22/2010US7741303 Stimulation of cellular regeneration and differentiation in the inner ear
06/22/2010US7741300 Methods of using nucleic acid vector-lipid complexes
06/22/2010US7741297 Cpg sites; point mutations; immunogens; cancer
06/22/2010US7741280 Multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments
06/22/2010US7741278 Modified proteins, designer toxins, and methods of making thereof
06/22/2010US7741276 Use of interleukin-18 inhibitors to inhibit tumor metastasis
06/22/2010US7741275 Short interfering RNA sequences specific for cathelicidin (cap18) gene for use in treatment and prevention of cell proliferative disorders
06/22/2010US7741273 Drug dosage device designed for delivery of antiinflammatory or anabolic compounds to intervertebral discs or articulating joints, and for insertion of drug depots into discs or joint capsules with minimal tissue disruption and minimal interference with normal joint motion
06/22/2010US7741272 Inhibiting angiogenesis in a mammal by administering Eph receptor antagonist ; cardiovascular disorders
06/22/2010US7741271 atopic diseases such as allergies, asthma, eosinophilia, glomerulonephritis; hyperplastic conditions such as cancer; T cell immunologobulin and mucin domain (TIM)
06/22/2010US7741115 for modulating or altering T cell function; found on lymphoid derived dendritic cells and display a limited homology to adhesion molecules; generating natural killer cells
06/22/2010US7741099 Recombinant, replication defective viral particles comprising chimeric hexon protein and hyper variable regions for use in improved gene delivery, vaccination, and gene therapy
06/22/2010US7741077 Method for the generation of genetically modified vertebrate precursor lymphocytes and use thereof for the production of heterologous binding proteins
06/22/2010US7741076 developing genetic constructs capable of expressing lipidated rP6 in e coli; used for to preventing disease caused by Haemophilus influenzae
06/22/2010US7741057 Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor
06/22/2010US7741056 Junctional Adhesion Molecule (JAM); treating and diagnosing disorders characterized the by the presence of antigens associated with inflammatory diseases and/or cancer; antagonist of a native sequence STIgMA polypeptide
06/22/2010US7741055 prostate cancer and benign prostatic hyperplasia; promote tissue regeneration and to facilitate wound healing
06/22/2010US7741039 Postweaning multisystemic wasting syndrome virus from pigs
06/22/2010US7741026 Baculovirus expressing the exogenous nucleotide sequence porcine circovirus-B (PCVB) open reading frame 2; transformed host cells for expressing immunogenic protein for protecting pigs including pregnant pigs
06/22/2010US7741024 used as immunogens to elicit immune reaction, screening assays, including as antigens to screen antibody libraries, as well as for drug screening and the identification of ligands
06/22/2010US7740872 Solvent extraction of lipids from cancer cells; mixture of cancer cell particles and carrier that induce immunology stimulation
06/22/2010US7740871 Cancer immunotherapy with a viral antigen-defined, immunomodulator-secreting cell vaccine
06/22/2010US7740870 Group B Streptococcus antigens and corresponding DNA fragments
06/22/2010US7740869 Phep, an amino acid permease of Staphylococcus aureus
06/22/2010US7740868 Activatable clostridial toxins
06/22/2010US7740867 Using insertional mutation as tool in detecting mycobaterial genes associated with infectivity; transposon mediated gene disruption
06/22/2010US7740866 Baculovirus expressing the exogenous nucleotide sequence porcine circovirus-B (PCVB) open reading frame 2; transformed host cells for expressing immunogenic protein for protecting pigs including pregnant pigs; adjuvant
06/22/2010US7740865 Circovirus sequences associated with piglet weight loss disease (PWD)
06/22/2010US7740864 Vaccines for diseases of fish
06/22/2010US7740863 Recombinant vaccine against West Nile Virus
06/22/2010US7740862 N-glycosylated at 0, 1, 2, 3, 4, 5 or 6 asparagine residues of mutant follicle stimulating hormone; increased glycosylation and longer half-lives; for inducing ovarian hyperstimulation in a mammal; fertilization therapies
06/22/2010US7740860 A lysine-glycine-lysine-glycine-Xaa pentapeptide residue complexed with one or more B-cell or T-cell determinants and targeting molecules; influenza type A vaccinations
06/22/2010US7740859 detection of anti-leishmanial antibodies in individuals suspected of infection with the protozoan parasite of the genus Leishmania especially Indian Leishmania strains; kits; vaccine and therapeutic agent to prevent and treat leishmaniasis
06/22/2010US7740858 High sensitivity and specificity of the serologic detection; rapid, simple, low cost test for commercially available, large scale screening of SARS patients
06/22/2010US7740857 Administering an isolated peptide; variants, derivatives or structural equivalents of cupredoxins or cytochrome
06/22/2010US7740856 Effect of BST2 on inflammation
06/22/2010US7740855 based on the enrichment of autologous CD4-reactive CD8 T cells; implementation of T cell vaccination
06/22/2010US7740854 Treatment of macrophage mediated disease
06/22/2010US7740853 Fcepsilon-pe chimeric protein for targeted treatment of allergy responses a method for its production and pharmaceutical compositions containing the same
06/22/2010US7740852 Binding molecules capable of neutralizing rabies virus and uses thereof
06/22/2010US7740851 Ultra high affinity neutralizing antibodies
06/22/2010US7740850 PDGFRβ-specific antibodies
06/22/2010US7740849 using compounds that increase endothelial nitric oxide synthase levels to treat pre-eclampsia and eclampsia
06/22/2010US7740848 Method of treatment of skin inflammation
06/22/2010US7740847 humanized anti-CD20 antibodies comprising a human IgG1 Fc region; for treating lymphoma
06/22/2010US7740846 treatment of mammals susceptible to or diagnosed with cancer, or with relapse tumor growth or relapse cancer cell growth
06/22/2010US7740845 Reducing tumor cells; isolated nucleic acids, proteins, peptides, cells, vectors, liposomes, antibodies, transgenic animals; drug screening; imaging, diagnosis
06/22/2010US7740844 have a high binding affinity to all five isoforms of human vascular endothelial growth factor (VEGF); for cancer, age-related macular degeneration (AMD), rheumatoid arthritis, and diabetic retinopathy
06/22/2010US7740843 Human monoclonal antibodies against human IL-4
06/22/2010US7740842 comprising an E25 anti-IgE antibody and acetic acid ; nasal sprays and slow release formulations drying or freeze-drying; treating an allergic disease
06/22/2010US7740841 Therapeutic method for reducing angiogenesis
06/22/2010US7740837 Genetically modified cells expressing a TGF beta inhibitor, the cells being lung cancer cells
06/22/2010US7740834 Murine zcytor17 ligand polypeptides
06/22/2010US7740833 Therapeutic uses of chemokine variants
06/22/2010US7740830 Imaging, diagnosis and treatment of disease
06/22/2010CA2441071C Tsg101-gag interaction and use thereof
1 ... 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 ... 1823